197 related articles for article (PubMed ID: 26611571)
1. Study the effects of saffron on depression and lipid profiles: A double blind comparative study.
Sahraian A; Jelodar S; Javid Z; Mowla A; Ahmadzadeh L
Asian J Psychiatr; 2016 Aug; 22():174-6. PubMed ID: 26611571
[TBL] [Abstract][Full Text] [Related]
2. Crocin, the main active saffron constituent, as an adjunctive treatment in major depressive disorder: a randomized, double-blind, placebo-controlled, pilot clinical trial.
Talaei A; Hassanpour Moghadam M; Sajadi Tabassi SA; Mohajeri SA
J Affect Disord; 2015 Mar; 174():51-6. PubMed ID: 25484177
[TBL] [Abstract][Full Text] [Related]
3. Crocus Sativus L. (saffron) versus sertraline on symptoms of depression among older people with major depressive disorders-a double-blind, randomized intervention study.
Ahmadpanah M; Ramezanshams F; Ghaleiha A; Akhondzadeh S; Sadeghi Bahmani D; Brand S
Psychiatry Res; 2019 Dec; 282():112613. PubMed ID: 31669837
[TBL] [Abstract][Full Text] [Related]
4. Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial.
Modabbernia A; Sohrabi H; Nasehi AA; Raisi F; Saroukhani S; Jamshidi A; Tabrizi M; Ashrafi M; Akhondzadeh S
Psychopharmacology (Berl); 2012 Oct; 223(4):381-8. PubMed ID: 22552758
[TBL] [Abstract][Full Text] [Related]
5. Saffron for treatment of fluoxetine-induced sexual dysfunction in women: randomized double-blind placebo-controlled study.
Kashani L; Raisi F; Saroukhani S; Sohrabi H; Modabbernia A; Nasehi AA; Jamshidi A; Ashrafi M; Mansouri P; Ghaeli P; Akhondzadeh S
Hum Psychopharmacol; 2013 Jan; 28(1):54-60. PubMed ID: 23280545
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of curcumin, and a saffron/curcumin combination for the treatment of major depression: A randomised, double-blind, placebo-controlled study.
Lopresti AL; Drummond PD
J Affect Disord; 2017 Jan; 207():188-196. PubMed ID: 27723543
[TBL] [Abstract][Full Text] [Related]
7. A placebo controlled randomized clinical trial of Crocus sativus L. (saffron) on depression and food craving among overweight women with mild to moderate depression.
Akhondzadeh S; Mostafavi SA; Keshavarz SA; Mohammadi MR; Hosseini S; Eshraghian MR
J Clin Pharm Ther; 2020 Feb; 45(1):134-143. PubMed ID: 31602695
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Crocus sativus (saffron) in treatment of major depressive disorder associated with post-menopausal hot flashes: a double-blind, randomized, placebo-controlled trial.
Kashani L; Esalatmanesh S; Eftekhari F; Salimi S; Foroughifar T; Etesam F; Safiaghdam H; Moazen-Zadeh E; Akhondzadeh S
Arch Gynecol Obstet; 2018 Mar; 297(3):717-724. PubMed ID: 29332222
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Saffron versus Fluoxetine in Treatment of Mild to Moderate Postpartum Depression: A Double-Blind, Randomized Clinical Trial.
Kashani L; Eslatmanesh S; Saedi N; Niroomand N; Ebrahimi M; Hosseinian M; Foroughifar T; Salimi S; Akhondzadeh S
Pharmacopsychiatry; 2017 Mar; 50(2):64-68. PubMed ID: 27595298
[No Abstract] [Full Text] [Related]
10. Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial.
Akhondzadeh S; Tahmacebi-Pour N; Noorbala AA; Amini H; Fallah-Pour H; Jamshidi AH; Khani M
Phytother Res; 2005 Feb; 19(2):148-51. PubMed ID: 15852492
[TBL] [Abstract][Full Text] [Related]
11. Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial.
Noorbala AA; Akhondzadeh S; Tahmacebi-Pour N; Jamshidi AH
J Ethnopharmacol; 2005 Feb; 97(2):281-4. PubMed ID: 15707766
[TBL] [Abstract][Full Text] [Related]
12. Intravenous administration of adenosine triphosphate and phosphocreatine combined with fluoxetine in major depressive disorder: protocol for a randomized, double-blind, placebo-controlled pilot study.
Chen Y; Cao X; Zang W; Tan S; Ou CQ; Shen X; Gao T; Zhao L
Trials; 2019 Jan; 20(1):34. PubMed ID: 30626424
[TBL] [Abstract][Full Text] [Related]
13. Influence of sex and menopausal status on response, remission, and recurrence in patients with recurrent major depressive disorder treated with venlafaxine extended release or fluoxetine: analysis of data from the PREVENT study.
Kornstein SG; Pedersen RD; Holland PJ; Nemeroff CB; Rothschild AJ; Thase ME; Trivedi MH; Ninan PT; Keller MB
J Clin Psychiatry; 2014 Jan; 75(1):62-8. PubMed ID: 24345717
[TBL] [Abstract][Full Text] [Related]
14. Effects of Saffron on Cognition, Anxiety, and Depression in Patients Undergoing Coronary Artery Bypass Grafting: A Randomized Double-Blind Placebo-Controlled Trial.
Moazen-Zadeh E; Abbasi SH; Safi-Aghdam H; Shahmansouri N; Arjmandi-Beglar A; Hajhosseinn Talasaz A; Salehiomran A; Forghani S; Akhondzadeh S
J Altern Complement Med; 2018 Apr; 24(4):361-368. PubMed ID: 29185780
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of the effects of saffron supplementation on the asthma clinical symptoms and asthma severity in patients with mild and moderate persistent allergic asthma: a double-blind, randomized placebo-controlled trial.
Zilaee M; Hosseini SA; Jafarirad S; Abolnezhadian F; Cheraghian B; Namjoyan F; Ghadiri A
Respir Res; 2019 Feb; 20(1):39. PubMed ID: 30795753
[TBL] [Abstract][Full Text] [Related]
16. The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial.
Davey CG; Chanen AM; Hetrick SE; Cotton SM; Ratheesh A; Amminger GP; Koutsogiannis J; Phelan M; Mullen E; Harrison BJ; Rice S; Parker AG; Dean OM; Weller A; Kerr M; Quinn AL; Catania L; Kazantzis N; McGorry PD; Berk M
Lancet Psychiatry; 2019 Sep; 6(9):735-744. PubMed ID: 31371212
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, randomized, placebo-controlled trial of saffron stigma (Crocus sativus L.) in mothers suffering from mild-to-moderate postpartum depression.
Tabeshpour J; Sobhani F; Sadjadi SA; Hosseinzadeh H; Mohajeri SA; Rajabi O; Taherzadeh Z; Eslami S
Phytomedicine; 2017 Dec; 36():145-152. PubMed ID: 29157808
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients.
Shahmansouri N; Farokhnia M; Abbasi SH; Kassaian SE; Noorbala Tafti AA; Gougol A; Yekehtaz H; Forghani S; Mahmoodian M; Saroukhani S; Arjmandi-Beglar A; Akhondzadeh S
J Affect Disord; 2014 Feb; 155():216-22. PubMed ID: 24289892
[TBL] [Abstract][Full Text] [Related]
19. Augmentation of fluoxetine with lovastatin for treating major depressive disorder, a randomized double-blind placebo controlled-clinical trial.
Ghanizadeh A; Hedayati A
Depress Anxiety; 2013 Nov; 30(11):1084-8. PubMed ID: 24115188
[TBL] [Abstract][Full Text] [Related]
20. Venlafaxine extended-release: a review of its use in the management of major depression.
Wellington K; Perry CM
CNS Drugs; 2001; 15(8):643-69. PubMed ID: 11524036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
